Dr. Luis A. Tejada, MD
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Years since graduation
- 40
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 513
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
PA license MD064992L -
Cardiovascular Disease Physician
PA license MD064992L
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- St Lukes Hospital Bethlehem, PA
- St Luke's Hospital - Upper Bucks Campus Quakertown, PA
- St Luke's Hospital - Grand View Campus Sellersville, PA
- St Luke's Hospital - Monroe Campus Stroudsburg, PA
- St Luke's Hospital - Easton Campus Easton, PA
Medical groups
- St Lukes Physician Group Inc (2,198 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 513
- Services billed
- 1,137
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 298 | 259 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 265 | 253 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 204 | 193 |
| Established patient office or other outpatient visit, 20-29 minutes | 113 | 102 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 97 | 96 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 75 | 60 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 62 | 62 |
| New patient office or other outpatient visit, 30-44 minutes | 43 | 43 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 33 | 33 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 21 | 21 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Atorvastatin Calcium Other prescribers in Bethlehem, PA | 524 |
| Metoprolol Succinate Other prescribers in Bethlehem, PA | 428 |
| Metoprolol Tartrate Other prescribers in Bethlehem, PA | 357 |
| Eliquis (apixaban) Other prescribers in Bethlehem, PA | 282 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Bethlehem, PA | 253 |
| Amlodipine Besylate Other prescribers in Bethlehem, PA | 220 |
| Lisinopril Other prescribers in Bethlehem, PA | 164 |
| Rosuvastatin Calcium Other prescribers in Bethlehem, PA | 141 |
| Furosemide Other prescribers in Bethlehem, PA | 139 |
| Xarelto (rivaroxaban) Other prescribers in Bethlehem, PA | 130 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 11 payments worth $432 in total to this clinician.
| Abbott Laboratories | $157 |
|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $116 |
| Insulet Corporation | $84.28 |
| E.r. Squibb & Sons, L.l.c. | $27.54 |
| Boston Scientific Corporation | $26.26 |
| Shockwave Medical, Inc | $21.07 |
| Food and Beverage | $432 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $49,736 in research payments for these studies, mostly to the institutions running them.
- A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS)
Janssen Research & Development, LLC
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.